Cannathemag
  • News
  • Magazine
  • Advertising
  • About Us
  • Language Services
  • Contacts
  • Search
  • CZ
Facebook Instagram

Cannabis against COVID-19? Promising research in Canada

26. May 2020 | Rubrika: Breaking News

The whole world is racing to find a cure for COVID-19: it’s hard not to get through the day without hearing the names of exotic drugs: remdesevir, chloroquine, and hydroxychloroquine. Some, like remdesevir, may be promising, as well as techniques like plasma transfusions. But since as yet there is no cure, scientists are examining thousands of possibilities in the fight against COVID-19.

Including cannabis.

Two cannabis researchers from the University of Lethbridge in Alberta, Canada – Olga and Igor Kovalchuk – recently decided to look into their previous findings on cannabinoid receptor types to see whether cannabis extracts might be useful in the fight against COVID-19.

Cannabinoids decrease the number of “doors in the building” by 70 per cent.

They found that some high-CBD, low-THC cannabis extracts have been proven to be effective in modulating ACE2 receptor levels. ACE2 is exactly the gateway which SARS-CoV-2 uses to invade the human body, and when it does, it creates a cytokine storm resulting in hyper-inflammation, which overwhelms healthy organs, damaging them in the serious, sometimes mortal ways we now associate with COVID-19.

Stunning results

“When COVID-19 started, Olga had the idea to revisit our data, to see if we could utilize it for COVID – there’s a lot of documented information about cannabis in inflammation,” said Ivan Kovalchuk. “It was like a joker card, you know, coronavirus. It just mixes up everybody’s plans,” Olga Kovalchuk added.

But the results were, to quote the scientists, “stunning”. Olga explained: “The virus has the capacity to bind to ACE-2, and get pulled into the cell, almost like a doorway.” Igor continued: “Imagine a cell being a large building. Cannabinoids decrease the number of doors in the building by, say, 70 per cent, so it means the level of entry will be restricted. So, therefore, you have more chance to fight it.”

Cannabis might offer a safe, low-cost, globally-available weapon in the arsenal against COVID-19.

Safety and low costs

The Kovalchuks have already submitted a report on their findings for publication. While CBD has not been clinically proven yet as effective against COVID-19 in any way, we are hopeful that research by the Kovalchuks and others will be allowed to continue and be supported in this direction.

In a time when heads of state are recommending dangerous cures like the internal use of bleach, or expensive drugs and treatments, cannabis might offer a safe, low-cost, globally-available weapon in the arsenal against COVID-19. Let’s echo the words of Olga Kovalchuk who said, “We need to bring it to the people – we need to fight the beast.”

Author: (eds)

Cannabis Therapy – online magazine for cannabis patients and experts alike. Issue No.2 coming soon!

Ohodnoťte tento článek
anti-inflammatory CBDcannabis extractscannabis researchCannabis therapyCBDCBD productshigh-CBD extractsinflammationlow-THC extractsmedical cannabis

You might like

  • press conferece Breaking News

    New campaign for rational cannabis regulation supports not only homegrowing but also regulated market

  • Breaking News

    Biobizz World Wide Organics and Juju Royal – Julian Marley launch their new 100% organic brand, embracing the Rastafarianessence

  • conference discussion Breaking News

    Hemp & Industry conference in Prague shows that hemp has a huge potential

1 Comment

  • Michelle Pickering says: 23. December 2020 at 16:39

    I believe your study is important. My husband and I are cannabis smokers and we strongly believe your theory is correct. Here’s why, my husbands mother and sister live with us and had Covid, none of us were tested but my M-I-L and S-I-L tested positive for antibodies while my husband and I did not. If you ever decide to do human trials for your research we would love to assist you.

    Reply
  • Write comment Cancel

    Search

    Latest News

    • Zdroj: unsplash.com

      Superior Treatment: Cannabis Extracts in Suppositories

      19. May 2025
    • Europe’s Largest Cannabis B2B Conference Is Coming Back To Berlin in One Week!

      22. April 2025
    • Source: Cannabis Embassy

      Centenary of Cannabis Prohibition: Global Cannabis History Year

      27. February 2025
    • Bern

      Join us in Bern for the largest European conference on medical cannabis

      21. January 2025
    Facebook YouTube SoundCloud
    • Advertising
    • Magazine
    • About Us
    • Contacts
    • Terms and Conditions

    CANNABIS THERAPY

    Magazine about medical uses of cannabis. For patients, health professionals as well as general public. Free of charge.

    Contact: office@konomag.cz

    Tel.: +420 737 300 375

    CATEGORIES

    • Advice
    • Breaking News
    • Experimental Treatment
    • Health
    • Inspiration
    • Interviews
    • Leaves of Grass
    • News
    • Pharmacopeia
    • Pharmacopoeia
    • Press Release
    • Research Reports
    • Uncategorized
    • Veterinary Medicine

    LATEST NEWS

    • Zdroj: unsplash.com

      Superior Treatment: Cannabis Extracts in Suppositories

      19. May 2025
    • Europe’s Largest Cannabis B2B Conference Is Coming Back To Berlin in One Week!

      22. April 2025

    SEARCH

    Follow us

    Facebook Instagram
  • © 2018-25 CANNABIS THERAPY magazine. All rights belong to their respective owners. Without their written consent it is prohibited to use parts or whole works in any way, particularly spreading and copying, mechanically or electronically, in English, Czech or any other language.

  • Cannathemag

    Manage consent to cookies and confirm your age
    We use technologies such as cookies to store and/or access device information. We do this to improve your browsing experience and display personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or a unique ID on this website. Disagreeing or withdrawing consent may adversely affect certain features and functions.

    This website also requires you to be of legal age. By accepting your preferences, you verify you are at least 18 years old.
    Functional Always active
    Technical storage or access is absolutely necessary for the legitimate purpose of enabling the use of a specific service that the subscriber or user has expressly requested, or for the sole purpose of carrying out the transmission of a message via an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    Technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    Technical storage or access is necessary to create user profiles in order to send advertising or track the user across a website or several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    Show preferences
    {title} {title} {title}
    Are you 18+?

    This website requires you to be of legal age. By clicking Yes, you verify you are at least 18 years old.